Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(4):380-381; doi:10.1093/jnci/91.4.380
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Dorgan, J. F.
Right arrow Articles by Hoover, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorgan, J. F.
Right arrow Articles by Hoover, R. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 4, 380-381, February 17, 1999
© 1999 Oxford University Press

CORRESPONDENCE

Re: Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women

Joanne F. Dorgan, Christopher Longcope, Frank Z. Stanczyk, Hugh E. Stephenson, Jr., Robert N. Hoover

Affiliations of authors: J. F. Dorgan, R. N. Hoover, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; C. Longcope, Departments of Obstetrics and Gynecology and Medicine, University of Massachusetts Medical School, Worcester; F. Z. Stanczyk, Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles; H. E. Stephenson, Jr., Department of Surgery, University of Missouri Health Sciences Center, Columbia.

Correspondence to: Joanne F. Dorgan, M.P.H., Ph.D., National Institutes of Health, Executive Plaza South, Rm. 7082, Bethesda, MD 20892-7234 (e-mail: jd7g@nih.gov).

Sex steroid hormone concentrations in serum (or plasma) have been positively related to postmenopausal breast cancer in several cohorts. Most recently, Hankinson et al. (1) reported in the Journal that postmenopausal women in the Nurses' Health Study with elevated levels of plasma estradiol, testosterone, and dehydroepiandrosterone (DHEA) sulfate were at a significantly increased risk when . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. Wang, E. M. John, and S. A. Ingles
Androgen Receptor and Prostate-Specific Antigen Gene Polymorphisms and Breast Cancer in African-American Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2990 - 2994.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Geisler and P. E. Lonning
Aromatase Inhibition: Translation into a Successful Therapeutic Approach
Clin. Cancer Res., April 15, 2005; 11(8): 2809 - 2821.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. K. Dunn, D. L. Wickerham, and L. G. Ford
Prevention of Hormone-Related Cancers: Breast Cancer
J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367.
[Abstract] [Full Text] [PDF]